NanHua Bio-medicine Co Ltd banner
N

NanHua Bio-medicine Co Ltd
SZSE:000504

Watchlist Manager
NanHua Bio-medicine Co Ltd
SZSE:000504
Watchlist
Price: 8.62 CNY -0.46% Market Closed
Market Cap: ¥2.8B

Relative Value

The Relative Value of one NanHua Bio-medicine Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 8.62 CNY, NanHua Bio-medicine Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NanHua Bio-medicine Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
NanHua Bio-medicine Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
NanHua Bio-medicine Co Ltd
SZSE:000504
2.8B CNY 22.7 -458.6 -115.7 -115.7
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 643 258.8 -159 901.4 -194 171.3 -191 955.6
US
Abbvie Inc
NYSE:ABBV
400.5B USD 6.7 171.3 16.6 23.5
US
Amgen Inc
NASDAQ:AMGN
204B USD 5.5 26.4 15.1 15.1
US
Gilead Sciences Inc
NASDAQ:GILD
190.3B USD 6.4 22.3 15.2 15.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.2B USD 10 30.3 23.2 24.2
US
Epizyme Inc
F:EPE
94.1B EUR 2 094 -534.3 -581.8 -566.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
83.7B USD 5.8 18.5 14.1 16.1
AU
CSL Ltd
ASX:CSL
73.9B AUD 3.3 17.1 11.7 14.6
NL
argenx SE
XBRU:ARGX
43.3B EUR 14.4 33.9 58.2 59.9
US
Seagen Inc
F:SGT
39.3B EUR 20.2 -61.8 -66.7 -60.2
P/S Multiple
Revenue Growth P/S to Growth
CN
N
NanHua Bio-medicine Co Ltd
SZSE:000504
Average P/S: 3 058 677.1
22.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
33 643 258.8
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.7
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
5.5
2%
2.8
US
Gilead Sciences Inc
NASDAQ:GILD
6.4
5%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10
10%
1
US
E
Epizyme Inc
F:EPE
2 094
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.8
9%
0.6
AU
CSL Ltd
ASX:CSL
3.3
5%
0.7
NL
argenx SE
XBRU:ARGX
14.4
49%
0.3
US
S
Seagen Inc
F:SGT
20.2
30%
0.7
P/E Multiple
Earnings Growth PEG
CN
N
NanHua Bio-medicine Co Ltd
SZSE:000504
Average P/E: 45.7
Negative Multiple: -458.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -159 901.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
171.3
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
26.4
18%
1.5
US
Gilead Sciences Inc
NASDAQ:GILD
22.3
14%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
30.3
17%
1.8
US
E
Epizyme Inc
F:EPE
Negative Multiple: -534.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.5
13%
1.4
AU
CSL Ltd
ASX:CSL
17.1
11%
1.6
NL
argenx SE
XBRU:ARGX
33.9
42%
0.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.8 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
N
NanHua Bio-medicine Co Ltd
SZSE:000504
Average EV/EBITDA: 22
Negative Multiple: -115.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 171.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.6
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
15.1
10%
1.5
US
Gilead Sciences Inc
NASDAQ:GILD
15.2
18%
0.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.2
15%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -581.8 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14.1
23%
0.6
AU
CSL Ltd
ASX:CSL
11.7
8%
1.5
NL
argenx SE
XBRU:ARGX
58.2
810%
0.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.7 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
N
NanHua Bio-medicine Co Ltd
SZSE:000504
Average EV/EBIT: 24.1
Negative Multiple: -115.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -191 955.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.5
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
15.1
2%
7.6
US
Gilead Sciences Inc
NASDAQ:GILD
15.2
11%
1.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.2
17%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -566.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.1
21%
0.8
AU
CSL Ltd
ASX:CSL
14.6
11%
1.3
NL
argenx SE
XBRU:ARGX
59.9
N/A N/A
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.2 N/A N/A